Preventing diabetes: Researchers measure loss of human pancreas cells

By Helen Dodson

(Medical Xpress) -- A Yale University-led research team has developed a way to measure the loss of insulin-producing islet cells in the human pancreas. The death of those beta cells leads to diabetes. The finding is a crucial step in developing therapies to preserve insulin production and slow or halt the progress of diabetes. The study appears in the June issue of the Journal of Nuclear Medicine.

Until now there has been no effective method for imaging pancreatic islet beta-cell mass in a non-invasive manner. Based on the work of Paul Harris and colleagues at Columbia University, the Yale team focused on the genetically expressed protein known as vesicular monoamine transporter type 2 (VMAT2). This protein facilitates the storage and release of some neurotransmitters, and is expressed simultaneously with insulin in .

The Yale team infused both healthy patients and those with type-1 diabetes with a radioactive tracer that targets VMAT2. Patients were then scanned with a PET camera to calculate the radioactivity concentration in the and measure the binding of the tracer.

Adjusting for dosage and body weight, the radiotracer binding among pancreatic cells was 40 percent less in type-1 diabetes patients than in healthy patients.

Senior author Gary W. Cline, associate professor of endocrinology at Yale School of Medicine, explained, “This tells us that we can now measure the loss of the pancreatic that produce insulin in diabetic patients. Being able to make these measurements will help in the development of a drug that can stop or slow the death of these cells, and thus prevent the damaging effects of type 1 diabetes.”

Other authors are Marc D. Normandin, Kitt F. Petersen, Kevin C. Herold, Yu-Shin Ding, Shu-Fei Lin, Sarita Naik, Krista Fowles, and Richard E. Carson of Yale; Daniel M. Skovronsky of Avid Radiopharmaceuticals; and Timothy J. McCarthy, Judith L. Treadwell, and Roberto A. Calle of Pfizer Global R&D.

Related Stories

Scientists use uterine stem cells to treat diabetes

Sep 14, 2011

Controlling diabetes may someday involve mining stem cells from the lining of the uterus, Yale School of Medicine researchers report in a new study published in the journal Molecular Therapy. The team treate ...

The new source of islet cells

Oct 25, 2007

The shortage of islet cells limits the development of islet transplantation. One new approach was reported in the October 21 issue of the World Journal of Gastroenterology because of its great significance in enhancing the ou ...

Promising advances in islet cell transplants for diabetes

Jun 09, 2008

University of Illinois at Chicago researchers have modified the procedure for islet cell transplantation and achieved insulin independence in diabetes patients with fewer but better-functioning pancreatic islet cells.

Recommended for you

Scientists discover gene controlling muscle fate

11 minutes ago

Scientists at the University of New Mexico have moved a step closer to improving medical science through research involving muscle manipulation of fruit flies. They discovered in the flight muscles of Drosophila ...

Study clues to aging bone loss

17 minutes ago

In Canada, bone fractures due to osteoporosis affect one in three women and one in five men over their lifetimes, costing the health care system more than $2.3 billion a year.

Sweat-eating bacteria may improve skin health

14 hours ago

Bacteria that metabolize ammonia, a major component of sweat, may improve skin health and some day could be used for the treatment of skin disorders, such as acne or chronic wounds. In a study conducted by AOBiome LLC, human ...

User comments